[Androgens in treatment of acquired bone marrow aplasia].
D000367:Age Factors; D000368:Aged; D000728:Androgens / Q000009:adverse effects / Q000627:therapeutic use*; D000741:Anemia, Aplastic / Q000188:drug therapy*; D004247:DNA / Q000096:biosynthesis; D004921:Erythropoietin / Q000502:physiology; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D008297:Male; D008710:Methenolone / Q000627:therapeutic use; D010110:Oxymetholone / Q000627:therapeutic use; D011379:Prognosis; D012313:RNA / Q000096:biosynthesis; D012075:Remission, Spontaneous; D013739:Testosterone / Q000494:pharmacology
D000728:Androgens; D004921:Erythropoietin; D013739:Testosterone; D012313:RNA; D004247:DNA; D008710:Methenolone; D010110:Oxymetholone
Androgeny w leczeniu nabytych aplazji szpiku.